Vital dyes for chromovitrectomy

Current Opinion in Ophthalmology

Volumn 18, Issue 3, 2007, Pages 179-187

  Rodrigues, Eduardo B ^a,c   Maia, Maurício ^a   Meyer, Carsten H ^b   Penha, Fernando M ^a   Dib, Eduardo ^a   Farah, Michel E ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF BONN   (Germany)

^c NONE   (Brazil)

Author keywords

Chromovitrectomy; Indocyanine green; Macular hole; Retina; Trypan blue

Indexed keywords

BROMOPHENOL BLUE; DISULFINE BLUE; DYE; FLUORESCEIN SODIUM; FLUOROMETHOLONE; INDOCYANINE GREEN; TRIAMCINOLONE ACETONIDE; TRYPAN BLUE;

CYTOTOXICITY; EPIRETINAL MEMBRANE; INDOCYANINE GREEN ANGIOGRAPHY; MEDICAL LITERATURE; MOLECULAR WEIGHT; PRIORITY JOURNAL; RETINA CELL; RETINA MACULA HOLE; REVIEW; RISK REDUCTION; SURGICAL RISK; VITAL STAIN; VITRECTOMY; VITREORETINOPATHY;

BENZENESULFONATES; BROMPHENOL BLUE; COLORING AGENTS; EPIRETINAL MEMBRANE; HUMANS; INDOCYANINE GREEN; RETINAL PERFORATIONS; ROSANILINE DYES; TRYPAN BLUE; VITRECTOMY;

EID: 34247257242     PISSN: 10408738     EISSN: None     Source Type: Journal    
DOI: 10.1097/ICU.0b013e32811080b5     Document Type: Review

References (66)

1. Rodrigues EB, Meyer CH, Kroll P. Chromovitrectomy: a new field in vitreoretinal surgery. Graefes Arch Clin Exp Ophthalmol 2005; 243:291-293.
2. Burk SE, Da Mata AP, Snyder ME, et al. Indocyanine green-assisted peeling of the retinal internal limiting membrane. Ophthalmology 2000; 107:2010-2014.
3. Rodrigues EB, Meyer CH, Farah ME, Kroll P. Intravitreal staining of the internal limiting membrane using indocyanine green in the treatment of macular holes. Ophthalmologica 2005; 219:251-262.
4. Wong KL, Hiscott P, Stanga P, et al. Trypan blue staining of the internal limiting membrane and epiretinal membrane during vitrectomy: visual results and histopathological findings. Br J Ophthalmol 2003; 87:216-219.
5. Hiebl W, Gunther B, Meinert H. Substances for staining biological tissues: use of dyes in ophthalmology. Klin Monatsbl Augenheilkd 2005; 222:309-311.
6. Teba FA, Mohr A, Eckardt C, et al. Trypan blue staining in vitreoretinal surgery. Ophthalmology 2003; 110:2409-2412.
7. Desmettre T, Devoisselle JM, Mordon S. Fluorescence properties and metabolic features of indocyanine green (ICG) as related to angiography. Surv Ophthalmol 2000; 45:15-27.
8. Rodrigues EB, Meyer CH, Schmidt JC, Kroll P. Surgical management of epiretinal membrane with indocyanine-green-assisted peeling [letter]. Ophthalmologica 2004; 218:73-74.
9. Maia M, Haller JA, Pieramici DJ, et al. Retinal pigment epithelium abnormalities after internal limiting membrane peeling guided by indocyanine green staining. Retina 2004; 24:157-160.
10. Nakamura T, Murata T, Hisatomi T, et al. Ultrastructure of the vitreoretinal interface following the removal of the internal limiting membrane using indocyanine green. Curr Eye Research 2004; 27:395-399.
11. Kwok AKH, Li WWY, Pang CP, et al. Indocyanine green staining and removal of internal limiting membrane in macular hole surgery: histology and outcome. Am J Ophthalmol 2001; 132:178-183.
12. Maia M, Kellner L, de Juan E Jr, et al. Effects of indocyanine green delivery over the retinal surface and into the subretinal space in rabbits. Retina 2004; 24:80-91.
13. Maia M, Margalit E, Tso MOM, et al. Effects of intravitreal indocyanine green injection in rabbits. Retina 2004; 24:69-79.
14. Jackson TL, Hillenkamp J, Knight BC, et al. Safety testing of indocyanine green and trypan blue using retinal pigment epithelium and glial cell cultures. Invest Ophthalmol Vis Sci 2004; 45:2778-2785.
15. Iriyama A, Uchida S, Yanagi Y, et al. Effects of indocyanine green on retinal ganglion cells. Invest Ophthalmol Vis Sci 2004; 45:943-947.
16. Ho J, Tsai RJ, Chen S, Chen H. Toxic effects of indocyanine green on retinal pigment epithelium related to osmotic effects of the solvent. Am J Ophthalmol 2003; 135:258.
17. Ho JD, Tsai RJ, Chen SN, Chen HC. Removal of sodium from the solvent reduces retinal pigment epithelium toxicity caused by indocyanine green: implications for macular hole surgery. Br J Ophthalmol 2004; 88:556-559.
18. Stalmans P, Van Aken EH, Veckeneer M, et al. Toxic effect of indocyanine green on retinal pigment epithelium related to osmotic effects of the solvent. Am J Ophthalmol 2002; 134:282-285.
19. Sheidow TG, Blinder KJ, Holekamp N, et al. Outcome results in macular hole surgery: an evaluation of internal limiting membrane peeling with and without indocyanine green. Ophthalmology 2003; 110:1697-1701.
20. Gass CA, Haritoglou C, Schaumberger M, Kampik A. Functional outcome of macular hole surgery with and without indocyanine green-assisted peeling of the internal limiting membrane. Graefes Arch Clin Exp Ophthalmol 2003; 241:716-720.
21. Ando F, Sasano K, Ohba N, et al. Anatomic and visual outcomes after indocyanine green-assisted peeling of the retinal internal limiting membrane in idiopathic macular hole surgery. Am J Ophthalmol 2004; 137:744-746.
22. Hillenkamp J, Saikia P, Herrmann WA, Framme C, Gabel VP, Sachs HG. Surgical removal of idiopathic epiretinal membrane with or without the assistance of indocyanine green: a randomised controlled clinical trial. Graefes Arch Clin Exp Ophthalmol 2006; Dec 21 [Epub ahead of print]. In a high level of evidence-based medicine the authors compare ICG use or not for epiretinal membrane removal.
23. Lochhead J, Jones E, Chui D, et al. Outcome of ICG-assisted ILM peel in macular hole surgery. Eye 2004; 18:804-808.
24. Slaughter K, Lee IL. Macular hole surgery with and without indocyanine green assistance. Eye 2004; 8:376-378.
25. Rodrigues EB, Meyer CH. Meta-analysis of chromovitrectomy with indocyanine green in macular hole surgery. Ophthalmologica 2007; 114:587-590.
26. Kodjikian L, Richter T, Halberstadt M, et al. Toxic effects of indocyanine green, infracyanine green and trypan blue on the human retinal pigmented epithelium. Graefes Arch Clin Exp Ophthalmol 2005; 243:917-925.
27. La Heij EC, Dieudonne SC, Mooy CM, et al. Immunohistochemical analysis of the internal limiting membrane peeled with infracyanine green. Am J Ophthalmol 2005; 140:1123-1125.
28. Rivett K, Kruger L, Radloff S. Infracyanine-assisted internal limiting membrane peeling in macular hole repair: does it make a difference? Graefes Arch Clin Exp Ophthalmol 2004; 242:393-396.
29. Jackson TL, Vote B, Knight BC, et al. Safety testing of infracyanine green using retinal pigment epithelium and glial cell cultures. Invest Ophthalmol Vis Sci 2004; 45:3697-3703.
30. Ullern M, Roman S, Dhalluin JF, et al. Contribution of intravitreal infracyanine green to macular hole and epimacular membrane surgery: preliminary study. J Fr Ophtalmol 2002; 25:915-920.
31. Marmor MF. Retinal detachment from hyperosmotic intravitreal injection. Invest Ophthalmol Vis Sci 1979; 18:1237-1244.
32. Melles GR, de Waard PW, Pameyer JH, Houdijn Beekhuis W. Trypan blue capsule staining to visualize the capsulorhexis in cataract surgery. J Cataract Refract Surg 1999; 25:7-9.
33. Veckeneer M, van Overdam K, Monzer J, et al. Ocular toxicity study of trypan blue injected into the vitreous cavity of rabbit eyes. Graefes Arch Clin Exp Ophthalmol 2001; 239:698-704.
34. Vote BJ, Russell MK, Joondeph BC. Trypan blue-assisted vitrectomy. Retina 2004; 24:736-738.
35. Luke C, Luke M, Dietlein TS, et al. Retinal tolerance to dyes. Br J Ophthalmol 2005; 89:1188-1191.
36. Jin Y, Uchida S, Yanagi Y, et al. Neurotoxic effects of trypan blue on rat retinal ganglion cells. Exp Eye Res 2005; 81:395-400.
37. Narayanan R, Kenney MC, Kamjoo S, et al. Trypan blue: effect on retinal pigment epithelial and neurosensory retinal cells. Invest Ophthalmol Vis Sci 2005; 46:304-309.
38. Mennel S, Thumann G, Peter S, et al. Influence of vital dyes on the function of the outer blood-retinal barrier in vitro. Klin Monatsbl Augenheilkd 2006; 223:568-576.
39. Jackson TL, Kwan AS, Laidlaw AH, Aylward W. Identification of retinal breaks using subretinal trypan blue injection. Ophthalmology 2006; Nov 20 [Epub ahead of print]. The authors introduce a new application for biostains in chromovitrectomy.
40. Tse CS, Bernstein IL. Corticosteroid aerosols in the treatment of asthma. Pharmacotherapy 1984; 4:334-342.
41. Jonas JB, Kreissig I, Degenring R. Intravitreal triamcinolone acetonide for treatment of intraocular proliferative, exudative, and neovascular diseases. Prog Retin Eye Res 2005; 24:587-611.
42. Burk SE, Da Mata AP, Snyder ME, et al. Visualizing vitreous using Kenalog suspension. J Cataract Refract Surg 2003; 29:645-651.
43. Guo S, Tutela AC, Wagner R, Caputo AR. A comparison of the effectiveness of four biostains in enhancing visualization of the vitreous. J Pediatr Ophthalmol Strabismus 2006; 43:281-284.
44. Kozak I, Cheng L, Mendez T, et al. Evaluation of the toxicity of subretinal triamcinolone acetonide in the rabbit. Retina 2006; 26:811-817.
45. Yu SY, Damico FM, Viola F, et al. Retinal toxicity of intravitreal triamcinolone acetonide: a morphological study. Retina 2006; 26:531-536.
46. Morrison VL, Koh HJ, Cheng L, et al. Intravitreal toxicity of the kenalog vehicle (benzyl alcohol) in rabbits. Retina 2006; 26:339-344.
47. Narayanan R, Mungcal JK, Kenney MC, et al. Toxicity of triamcinolone acetonide on retinal neurosensory and pigment epithelial cells. Invest Ophthalmol Vis Sci 2006; 47:722-728.
48. Ruiz-Moreno JM, Montero JA, Bayon A, et al. Retinal toxicity of intravitreal triamcinolone acetonide at high doses in the rabbit. Exp Eye Res 2007; 84:342-348.
49. Jahnke KD. A simple technique for staining chrysocystidia with patent blue V. Mycologia 1984; 76:940-943.
50. Sokolowski J, Engeset A. Toxiceffect of patent blue violet on rat lymph node lymphocytes. Lymphology 1974; 7:28-31.
51. Mennel S, Meyer CH, Tietjen A, et al. Patent blue: a novel vital dye in vitreoretinal surgery. Ophthalmologica 2006; 220:190-193. This is the first report on the clinical use of patent blue for chromovitrectomy in humans.
52. Luke C, Luke M, Sickel W, Schneider T. Effects of patent blue on human retinal function. Graefes Arch Clin Exp Ophthalmol 2006; 244:1188-1190.
53. Westermeier R. Sensitive, quantitative, and fast modifications for Coomassie blue staining of polyacrylamide gels. Proteomics 2006; 6:61-64.
54. Enaida H, Hisatomi T, Goto Y, et al. Preclinical investigation of internal limiting membrane staining and peeling using intravitreal brilliant blue G. Retina 2006; 26:623-630. Animal experiments were performed to evaluate brilliant blue indications in chromovitrectomy.
55. Hisatomi T, Enaida H, Matsumoto H, et al. Staining ability and biocompatibility of brilliant blue G: preclinical study of brilliant blue G as an adjunct for capsular staining. Arch Ophthalmol 2006; 124:514-519. This describes preclinical investigation of anterior capsule staining using intravitreal brilliant blue G.
56. Enaida H, Hisatomi T, Hata Y, et al. Brilliant blue G selectively stains the internal limiting membrane/brilliant blue G-assisted membrane peeling. Retina 2006; 26:631-636. A pilot study in humans demonstrated brilliant blue as outstanding vital dye for internal limiting membrane staining.
57. Ozawa T, Britz GW, Kinder DH, et al. Bromophenol blue staining of tumors in a rat glioma model. Neurosurgery 2005; 57:1041-1047.
58. Haritoglou C, Yu A, Freyer W, et al. An evaluation of novel vital dyes for intraocular surgery. Invest Ophthalmol Vis Sci 2005; 46:3315-3322.
59. Schuettauf F, Haritoglou C, May CA, et al. Administration of novel dyes for intraocular surgery: an in vivo toxicity animal study. Invest Ophthalmol Vis Sci 2006; 47:3573-3578.
60. Haritoglou C, Tadayoni R, May CA, et al. Short-term in vivo evaluation of novel vital dyes for intraocular surgery. Retina 2006; 26:673-678.
61. Larsen M. Ocular fluorometry methodological improvements and clinical studies - with special reference to the blood-retina barrier permeability to fluorescein and fluorescein glucuronide. Acta Ophthalmol Suppl 1993; 211:1-52.
62. Abrams GW, Topping T, Machemer R. An improved method for practice vitrectomy. Arch Ophthalmol 1978; 96:521-525.
63. Das T, Vedantham V. Visualization of clear vitreous during vitreous surgery for macular hole: a safety and efficacy study. Clin Exp Ophthalmol 2004;32:55-57.
64. Hata Y, Enaida H, Sassa Y, et al. Preclinical investigation of fluorometholone acetate as a potential new adjuvant during vitreous surgery. Graefes Arch Clin Exp Ophthalmol 2006; Dec 21 [Epub ahead of print].
65. Czajka MP, McCuen BW 2nd, Cummings TJ, et al. Effects of indocyanine green on the retina and retinal pigment epithelium in a porcine model of retinal hole. Retina 2004; 24:275-282.
66. Meyer CH, Rodrigues EB. A novel applicator for the selective painting of preretinal structures during vitreoretinal surgery. Graefes Arch Clin Exp Ophthalmol 2005; 243:487-489.